Last reviewed · How we verify
Diclofenac oral + scopolamina oral
Diclofenac oral + scopolamina oral is a NSAID + anticholinergic combination Small molecule drug developed by Hospital de Clinicas de Porto Alegre. It is currently FDA-approved for Acute pain with associated nausea or gastrointestinal cramping, Postoperative pain management. Also known as: Diclofenac 50 mg oral tablet, scopolamin 10 mg oral tablet.
This combination uses diclofenac to reduce pain and inflammation via COX inhibition, and scopolamine to reduce gastrointestinal motility and secretions, thereby decreasing nausea and cramping associated with the NSAID.
This combination uses diclofenac to reduce pain and inflammation via COX inhibition, and scopolamine to reduce gastrointestinal motility and secretions, thereby decreasing nausea and cramping associated with the NSAID. Used for Acute pain with associated nausea or gastrointestinal cramping, Postoperative pain management.
At a glance
| Generic name | Diclofenac oral + scopolamina oral |
|---|---|
| Also known as | Diclofenac 50 mg oral tablet, scopolamin 10 mg oral tablet |
| Sponsor | Hospital de Clinicas de Porto Alegre |
| Drug class | NSAID + anticholinergic combination |
| Target | COX-1/COX-2 (diclofenac); muscarinic acetylcholine receptors (scopolamine) |
| Modality | Small molecule |
| Therapeutic area | Pain management / Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
Diclofenac is a nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, providing analgesic and anti-inflammatory effects. Scopolamine is an anticholinergic agent that blocks muscarinic acetylcholine receptors in the gastrointestinal tract, reducing motility, secretions, and associated nausea—effects that help mitigate NSAID-induced GI side effects.
Approved indications
- Acute pain with associated nausea or gastrointestinal cramping
- Postoperative pain management
Common side effects
- Dry mouth
- Dizziness
- Gastrointestinal upset (reduced vs. diclofenac alone)
- Blurred vision
- Tachycardia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diclofenac oral + scopolamina oral CI brief — competitive landscape report
- Diclofenac oral + scopolamina oral updates RSS · CI watch RSS
- Hospital de Clinicas de Porto Alegre portfolio CI
Frequently asked questions about Diclofenac oral + scopolamina oral
What is Diclofenac oral + scopolamina oral?
How does Diclofenac oral + scopolamina oral work?
What is Diclofenac oral + scopolamina oral used for?
Who makes Diclofenac oral + scopolamina oral?
Is Diclofenac oral + scopolamina oral also known as anything else?
What drug class is Diclofenac oral + scopolamina oral in?
What development phase is Diclofenac oral + scopolamina oral in?
What are the side effects of Diclofenac oral + scopolamina oral?
What does Diclofenac oral + scopolamina oral target?
Related
- Drug class: All NSAID + anticholinergic combination drugs
- Target: All drugs targeting COX-1/COX-2 (diclofenac); muscarinic acetylcholine receptors (scopolamine)
- Manufacturer: Hospital de Clinicas de Porto Alegre — full pipeline
- Therapeutic area: All drugs in Pain management / Gastroenterology
- Indication: Drugs for Acute pain with associated nausea or gastrointestinal cramping
- Indication: Drugs for Postoperative pain management
- Also known as: Diclofenac 50 mg oral tablet, scopolamin 10 mg oral tablet
- Compare: Diclofenac oral + scopolamina oral vs similar drugs
- Pricing: Diclofenac oral + scopolamina oral cost, discount & access